RUBY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RUBY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net Policyholder Benefits/Claims only applies to insurance companies.
Dannielle Appelhans | officer: CEO and President | C/O RUBIUS THERAPEUTICS, INC., 399 BINNEY STREET, SUITE 300, CAMBRIDGE MA 02139 |
Pablo J Cagnoni | director, officer: Chief Executive Officer | ONYX PHARMACEUTICALS, INC., 249 E. GRAND AVE., SOUTH SAN FRANCISCO CA 94080 |
Laurence A. Turka | officer: Chief Scientific Officer | C/O RUBIUS THERAPEUTICS, INC., 399 BINNEY ST., SUITE 300, CAMBRIDGE MA 02139 |
Susanne Schaffert | director | C/O RUBIUS THERAPEUTICS, INC., 399 BINNEY STREET, SUITE 300, CAMBRIDGE MA 02139 |
David R Epstein | director | INTERNATIONAL FLAVORS & FRAGRANCES INC., 521 W. 57TH STREET, NEW YORK NY 10019 |
Maiken Keson-brookes | officer: CLO & Corp. Secretary | 35 OAK HILL ROAD, FAYVILLE MA 01745 |
Flagship Ventures Fund V, L.p. | 10 percent owner | ONE MEMORIAL DRIVE, 7TH FLOOR, CAMBRIDGE MA 02142 |
Flagship Ventures Opportunities Fund I General Partner Llc | 10 percent owner | 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 |
Flagship Ventures Opportunities Fund I, L.p. | 10 percent owner | ONE MEMORIAL DRIVE, 7TH FLOOR, CAMBRIDGE MA 02142 |
Flagship Ventures Fund V General Partner Llc | 10 percent owner | 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 |
Flagship Ventures Fund Iv General Partner Llc | 10 percent owner | 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 |
Flagship Ventures Fund Iv, L.p. | 10 percent owner | 55 CAMBRIDGE PARKWAY, 8TH FLOOR, CAMBRIDGE MA 02142 |
Noubar Afeyan | director, 10 percent owner | C/O FLAGSHIP PIONEERING, INC., 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 |
Jose Carmona | officer: Chief Financial Officer | C/O INNOCOLL HOLDINGS PLC, 3803 WEST CHESTER PIKE, NEWTOWN SQUARE PA 19073 |
Christina M. Coughlin | officer: Chief Medical Officer | C/O RUBIUS THERAPEUTICS, INC., 399 BINNEY ST., SUITE 300, CAMBRIDGE MA 02139 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.